Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer. | World J Surg Oncol | 2022 | 35650630 | PubTator, text mining | PubMed |
| Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer. | J Immunol Res | 2022 | 35647201 | PubTator, text mining | PubMed |
| New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer. | Front Cell Dev Biol | 2022 | 35646934 | PubTator, text mining | PubMed |
| Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma. | Front Genet | 2022 | 35646059 | PubTator, text mining | PubMed |
| Animal Models of Systemic Sclerosis: Using Nailfold Capillaroscopy as a Potential Tool to Evaluate Microcirculation and Microangiopathy: A Narrative Review. | Life (Basel) | 2022 | 35629370 | PubTator, text mining | PubMed |
| The Regulatory-T-Cell Memory Phenotype: What We Know. | Cells | 2022 | 35626725 | PubTator, text mining | PubMed |
| TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma. | Brain Sci | 2022 | 35625048 | PubTator, text mining | PubMed |
| Chromatin accessibility analysis reveals regulatory dynamics and therapeutic relevance of Vogt-Koyanagi-Harada disease. | Commun Biol | 2022 | 35618758 | PubTator, text mining | PubMed |
| Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. | Front Immunol | 2022 | 35615359 | PubTator, text mining | PubMed |
| Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma. | Bioengineered | 2022 | 35609322 | PubTator, text mining | PubMed |
| ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. | Front Oncol | 2022 | 35586489 | PubTator, text mining | PubMed |
| Tissue Resident and Migratory Group 2 Innate Lymphoid Cells. | Front Immunol | 2022 | 35572538 | PubTator, text mining | PubMed |
| GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer. | Transl Cancer Res | 2022 | 35571651 | PubTator, text mining | PubMed |
| Cytokines: Can Cancer Get the Message? | Cancers (Basel) | 2022 | 35565306 | PubTator, text mining | PubMed |
| HIV-2 Neutralization Sensitivity in Relation to Co-Receptor Entry Pathways and Env Motifs. | Int J Mol Sci | 2022 | 35563157 | PubTator, text mining | PubMed |
| Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma. | J Transl Med | 2022 | 35562760 | PubTator, text mining | PubMed |
| Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses. | Front Immunol | 2022 | 35558067 | PubTator, text mining | PubMed |
| α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes. | Proc Natl Acad Sci U S A | 2022 | 35537053 | PubTator, text mining | PubMed |
| Decaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma. | Cancer Manag Res | 2022 | 35535267 | PubTator, text mining | PubMed |
| β2-Integrins - Regulatory and Executive Bridges in the Signaling Network Controlling Leukocyte Trafficking and Migration. | Front Immunol | 2022 | 35529883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=33